Have you ever read a drug ad that said, "This medicine cuts your risk of heart attack in half"? It sounds amazing-until you realize that if your original risk was 2%, cutting it in half means going down to 1%. That’s not a miracle. It’s a small change. And that’s the problem. Most people, even doctors, mix up two simple numbers: absolute risk and relative risk. One tells you what actually happened. The other makes it sound like a game-changer. Knowing the difference could change how you decide whether to take a drug-or avoid it.

What Absolute Risk Really Means

Absolute risk is the plain, real number. It answers: "Out of 100 people like me, how many will have this side effect?" It doesn’t compare groups. It just shows what happens in real life.

For example, let’s say a drug causes severe nausea in 5 out of every 100 people who take it. That’s an absolute risk of 5%. Simple. No tricks. If you’re one of those 100, you have a 5% chance of feeling sick. That’s it.

Same goes for benefits. If a statin reduces your chance of having a heart attack from 4% to 3%, the absolute risk reduction is just 1 percentage point. That’s not nothing-but it’s not a 75% win, either. Absolute risk doesn’t lie. It’s the baseline. And if you don’t know your baseline, you can’t tell if a treatment actually helped.

How Relative Risk Tricks Your Brain

Relative risk is where things get slippery. It’s not about what happened. It’s about comparing two groups: those who took the drug vs. those who didn’t. It’s a ratio. And ratios can make tiny changes look huge.

Take that same statin. Your heart attack risk drops from 4% to 3%. Absolute risk reduction? 1%. Relative risk reduction? 25%. Here’s how: (4% - 3%) ÷ 4% = 0.25, or 25%. That’s the number you’ll see in ads: "Reduces heart attack risk by 25%!"

Now imagine a drug that cuts cancer risk from 0.01% to 0.005%. Absolute change? Just 0.005%. But relative? 50% reduction. That’s a 50% win-on a risk so small, it’s practically invisible. And yet, companies will still say: "Cut your cancer risk in half!"

Relative risk doesn’t lie. But it doesn’t tell the whole story. It’s like saying, "I doubled my savings!"-when you went from $2 to $4. It’s mathematically true. But it doesn’t mean you’re rich.

Why This Matters in Real Life

Let’s look at a real case. A 2022 Reddit thread from a primary care doctor in Sydney shared this: a patient refused statins because they’d read online that the drug "cuts heart attack risk in half." The patient thought it meant half of all people taking it would avoid heart attacks. That’s not what it means. It meant their personal risk went from 2% to 1%. The patient was scared off by a misleading number.

Another example: venlafaxine, an antidepressant. Studies show 20% of users get sexual side effects. On placebo? 8.3%. The relative risk? 2.41-meaning you’re more than twice as likely to have this side effect. Sounds scary. But the absolute difference? Only 11.7 percentage points. So out of 100 people, 12 more will have this issue because of the drug. That’s not trivial. But it’s not a 241% chance of disaster. It’s a 12% increase.

Pharmaceutical ads love relative risk because it sounds impressive. A 2021 study found 78% of U.S. direct-to-consumer drug ads used relative risk without mentioning absolute numbers. Meanwhile, in Europe, regulators require both. Here, you’re left guessing.

How to Read the Numbers Right

You don’t need to be a statistician. Just ask two questions:

1. What was the original risk? If the ad says "50% reduction," ask: "50% reduction from what?" If they don’t say, walk away.
2. How many people actually benefit-or get hurt? Look for numbers like "1 in 100," "5 out of 1,000," or "10% more likely." Those are absolute. They’re real.

Here’s a trick: always convert relative risk into absolute terms. If a drug says it "reduces risk by 30%," and you know your baseline risk is 10%, then the absolute reduction is 3 percentage points (30% of 10% = 3%). So instead of 10 in 100 getting the problem, now it’s 7 in 100. That’s helpful. But not earth-shattering.

And if you’re worried about side effects? Look for the absolute increase. If a drug raises your chance of a rare side effect from 0.1% to 0.2%, that’s a 100% relative increase. Sounds scary. But in real terms? One extra person out of 1,000. That’s not nothing-but it’s not a reason to panic either.

What Doctors and Regulators Are Doing About It

It’s not just patients who get confused. A 2019 study found that 60% of doctors couldn’t correctly convert relative risk to absolute terms. That’s alarming. If clinicians don’t understand it, how can they explain it?

Thankfully, things are changing. The FDA issued draft guidance in January 2023 saying direct-to-consumer ads must show both absolute and relative risks. The Cochrane Collaboration now provides standard templates for risk communication, used by 37 major journals. Harvard Medical School added a mandatory course on interpreting medical stats in 2022. And in Australia, the TGA (Therapeutic Goods Administration) requires both numbers in patient information leaflets for prescription drugs.

But enforcement is still patchy. Many ads still hide the absolute numbers. And many websites still push relative risk as the main story.

What You Can Do

Here’s your checklist before you start a new medication:

• Ask your doctor: "What’s my baseline risk?" (e.g., "How likely am I to have a stroke without this drug?")
• Ask: "How much does this drug reduce that risk?" (They should give you a percentage point number, not just "50%.")
• Ask: "What’s the absolute increase in side effects?" (Not just "twice as likely.")
• Ask: "How many people need to take this for one person to benefit?" (That’s called Number Needed to Treat, or NNT. If it’s 50, that means 49 people get no benefit-and might still get side effects.)

And if you see a number like "reduces risk by 40%" without context? Don’t trust it. Demand the numbers behind it.

Why This Isn’t Just About Drugs

This isn’t just about statins or antidepressants. It’s about how we make decisions based on numbers. The same trick is used in nutrition ads ("Boosts immunity by 200%!"), insurance plans ("Save 50% on premiums!") and even fitness products ("Lose 70% more fat!").

When you learn to spot the difference between absolute and relative risk, you’re not just becoming a smarter patient. You’re becoming a smarter consumer. You stop being swayed by flashy percentages. You start asking: "What does this actually mean for me?"

Because in medicine, as in life, the biggest risks aren’t the ones that sound scary. They’re the ones no one tells you about.